Stage III Vulvar Cancer Completed Phase 2 Trials for Cisplatin (DB00515)

IndicationStatusPhase
DBCOND0028772 (Stage III Vulvar Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00068406Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the VulvaTreatment